Why Now Is the Time to Buy Oracle Stock

Oracle reported a 325% year-over-year jump in Remaining Performance Obligations to $553 billion in fiscal Q3 2026, while overall revenue rose 22% and cloud infrastructure revenue surged 84% to nearly $5 billion. Management reaffirmed fiscal 2026 guidance and raised fiscal 2027 expectations, with revenue projected to reach $90 billion in 2027. Despite recent share weakness of more than 57% from the September 2025 high, the article argues the valuation has become more reasonable at about 18x forward P/E.

Analysis

ORCL’s backlog inflection is more important as a funding signal than a demand headline: it effectively de-risks multi-year capex and should compress the market’s skepticism discount on cloud infrastructure buildout. The market is still pricing this like a capex-heavy cyclical, but the economics are closer to a contracted utility with an AI-assisted step-up in utilization, which supports multiple re-rating if execution stays clean through the next 2-3 quarters.

The second-order winner is the semiconductor and networking ecosystem tied to Oracle’s capacity expansion, not just ORCL itself. Incremental cloud spend tends to ripple into accelerated demand for GPUs, switches, optics, and power infrastructure; the key beneficiary is NVDA, while the more obscure upside sits in high-bandwidth networking and data-center power suppliers. Conversely, legacy on-prem software peers face a tougher sales environment because Oracle’s visible growth gives CIOs a stronger benchmark for migrating workloads and budget share.

The main risk is not demand collapse but timing mismatch: if capex outruns near-term monetization, ORCL could see margin pressure and another de-rating even with strong bookings. Over the next 1-2 earnings prints, the stock likely trades on commentary around conversion of backlog to revenue, not backlog itself; any slip in 2027 guide cadence or capex intensity could reverse the recent recovery quickly. In contrast, if management shows improving free-cash-flow conversion, the valuation reset from peak levels can continue because forward multiples are still not demanding relative to the growth path.

The contrarian read is that the selloff may have overshot because investors are extrapolating capex risk while underweighting the option value of a larger AI infrastructure franchise. The market is implicitly assuming that heavy spending destroys returns; the more relevant question is whether Oracle can lock in multi-year capacity at today’s build costs and monetize it into a scarcity asset. If that holds, the current setup looks less like a value trap and more like a staged re-rating with an interim drawdown risk.

Key Decisions for Investors

• Long ORCL on weakness over the next 2-6 weeks; use a staggered entry and size for a 6-12 month hold. Risk/reward is attractive if the market continues to price the story as capex-heavy while backlog conversion improves; downside is a near-term margin miss or capex escalation.
• Pair trade: long ORCL / short a basket of slower-growth legacy enterprise software names over 3-6 months. The thesis is that visible AI infrastructure demand should pull budget share toward winners with contracted revenue visibility, while weaker peers face relative multiple compression.
• Overweight NVDA as a second-order beneficiary on a 3-9 month horizon. Oracle’s expansion supports incremental data-center buildout demand; the risk is that this remains sentiment-driven unless order flow from hyperscaler/enterprise infra spend accelerates.
• Consider a call spread in ORCL for the next 2 earnings cycles rather than outright stock if you want defined risk. This captures re-rating potential if management reiterates guidance and margin concerns ease, while limiting drawdown if the market keeps punishing capex.
• Avoid chasing the move in the next few days; wait for post-earnings or broad tech weakness to build positions. The better entry is when volatility spikes on capex headlines, not when momentum is already pricing perfect execution.